1. Home
  2. APTO vs NUKK Comparison

APTO vs NUKK Comparison

Compare APTO & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APTO
  • NUKK
  • Stock Information
  • Founded
  • APTO 1986
  • NUKK 2013
  • Country
  • APTO Canada
  • NUKK United States
  • Employees
  • APTO N/A
  • NUKK N/A
  • Industry
  • APTO Biotechnology: Biological Products (No Diagnostic Substances)
  • NUKK Blank Checks
  • Sector
  • APTO Health Care
  • NUKK Finance
  • Exchange
  • APTO Nasdaq
  • NUKK Nasdaq
  • Market Cap
  • APTO 7.2M
  • NUKK 6.3M
  • IPO Year
  • APTO N/A
  • NUKK N/A
  • Fundamental
  • Price
  • APTO $0.39
  • NUKK $1.83
  • Analyst Decision
  • APTO Strong Buy
  • NUKK
  • Analyst Count
  • APTO 3
  • NUKK 0
  • Target Price
  • APTO $6.00
  • NUKK N/A
  • AVG Volume (30 Days)
  • APTO 70.7K
  • NUKK 830.5K
  • Earning Date
  • APTO 11-08-2024
  • NUKK 11-29-2024
  • Dividend Yield
  • APTO N/A
  • NUKK N/A
  • EPS Growth
  • APTO N/A
  • NUKK N/A
  • EPS
  • APTO N/A
  • NUKK N/A
  • Revenue
  • APTO N/A
  • NUKK $10,752,616.00
  • Revenue This Year
  • APTO N/A
  • NUKK N/A
  • Revenue Next Year
  • APTO N/A
  • NUKK N/A
  • P/E Ratio
  • APTO N/A
  • NUKK N/A
  • Revenue Growth
  • APTO N/A
  • NUKK N/A
  • 52 Week Low
  • APTO $0.33
  • NUKK $1.30
  • 52 Week High
  • APTO $2.91
  • NUKK $79.03
  • Technical
  • Relative Strength Index (RSI)
  • APTO 50.13
  • NUKK 41.68
  • Support Level
  • APTO $0.36
  • NUKK $2.23
  • Resistance Level
  • APTO $0.41
  • NUKK $3.33
  • Average True Range (ATR)
  • APTO 0.02
  • NUKK 0.48
  • MACD
  • APTO -0.00
  • NUKK -0.05
  • Stochastic Oscillator
  • APTO 43.33
  • NUKK 28.09

About APTO Aptose Biosciences Inc.

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically, the majority of its revenue is generated from the United Kingdom and the rest from the United States and Malta.

Share on Social Networks: